Pharmasight
Sign inSee a worked packBook the bench
Scale & Govern · Sware

Res_Q platform + Sware's people resources drove validation time and cost savings

Biopharmaceutical Company (unnamed)Scale & GovernSwareRes_Q

Sware is a GxP validation platform whose entire commercial focus is life sciences — used specifically to validate AI/ML systems' explainable, traceable decisions for regulatory scrutiny.

This sits in the Scale & Govern stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to monitor, govern and keep validating an AI system once it is already live in production.

Source

Published by Sware on its own site — read the original case study on sware.com ↗

More like this

Related use cases

  1. 01projected to save 1.5 FTE/year on ERP validation; now FDA audit-ready with end-to-end traceable, data-first validationGlobal Biologics CDMO (unnamed)SwareScale & Govern
  2. 02user-friendly Res_Q software enabled streamlined, access-controlled auditsGlobal Gene Therapy CDMO (unnamed)SwareScale & Govern
  3. 03joint GxP-compliant paperless-workflow offering for life sciences built on Res_QNuvolo (technology partner, not an end customer)SwareScale & Govern
  4. 04cut validation time 30–40% by centralizing validation across multiple sites on Res_QBiotechnology Company (unnamed)SwareScale & Govern
  5. 05shifted from CSV to CSA, accelerating validation by 75% and freeing ~1 FTE of laborPharmaceutical Research Company (unnamed)SwareScale & Govern
  6. 06validation workstream execution time cut from days to hoursMolecular Medicine Company (unnamed)SwareScale & Govern